Evaluation of People With Gastrointestinal Disease
Evaluation of Patients With Gastrointestinal Disease
2 other identifiers
observational
2,761
1 country
1
Brief Summary
Background: \- Gastrointestinal diseases and disorders affect the throat, stomach, and intestines. There are many different kinds of these diseases. Clinical trials are being developed to study new ways to treat them. People who are interested in clinical trials need to be screened before they can take part in the studies. Researchers want to evaluate people with different stomach and intestine disorders to see if they are eligible for clinical trials. Objectives: \- To study people who have gastrointestinal disorders and see if they are eligible for clinical trials. Eligibility: \- Individuals at least 18 years of age who have or may have a gastrointestinal disorder. Design:
- Participants will be screened with a physical exam and medical history. Blood, urine, and stool samples will be collected. Imaging studies such as x-rays and ultrasound will check to see if the disorder has affected other organs.
- Participants may have tests as needed depending on their disorder. These tests include the following:
- Colonoscopy and endoscopy of the large intestine, esophagus, and stomach.
- Stomach acid analysis to look at stomach pH levels.
- Wireless capsule endoscopy to take pictures of the small intestine.
- Hydrogen breath testing to study issues like bloating, diarrhea, and constipation.
- Sitz Marker Study to see how fast stool moves through the colon.
- Participants may donate extra blood, urine, or stool samples for study. They may also donate stomach contents or tissue from the gut.
- Treatment will not be provided as part of this study. However, participants may be admitted to other clinical trials.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2012
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 11, 2012
CompletedFirst Posted
Study publicly available on registry
July 13, 2012
CompletedStudy Start
First participant enrolled
July 27, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 15, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
February 15, 2022
CompletedFebruary 18, 2022
February 1, 2022
9.6 years
July 11, 2012
February 16, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Patients with gastrointestinal disease
screening protocol for gastrointestinal diseases.
until protocol closes
Secondary Outcomes (1)
Allow outpatient evaluation and follow-up of patients with a variety of gastrointestinal diseases for the purposes of physician education in the NIDDK's accredited gastroenterology training program.
until protocol closes
Study Arms (1)
Study Cohort
Patients with known or suspected gastrointestinal disease
Eligibility Criteria
Patients with known or suspected gastrointestinal disease.@@@@@@
You may qualify if:
- Known or suspected gastrointestinal disorders.
- Patients greater than or equal to 18 years of age capable of providing informed consent.
- Existence of a referring community physician who would be able to manage care outside of the NIH.
You may not qualify if:
- Significant medical illnesses that the investigators feel may interfere with potential evaluations.
- Any medical, psychiatric, or social conditions which, in the opinion of the investigators, would make participation in this protocol not in the best interest of the patient.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, Maryland, 20892, United States
Related Links
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Sheila Kumar, M.D.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- NIH
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 11, 2012
First Posted
July 13, 2012
Study Start
July 27, 2012
Primary Completion
February 15, 2022
Study Completion
February 15, 2022
Last Updated
February 18, 2022
Record last verified: 2022-02